Stephen Gately

4.1k total citations · 1 hit paper
40 papers, 3.5k citations indexed

About

Stephen Gately is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Stephen Gately has authored 40 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Stephen Gately's work include Angiogenesis and VEGF in Cancer (14 papers), Protease and Inhibitor Mechanisms (6 papers) and Fibroblast Growth Factor Research (5 papers). Stephen Gately is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Protease and Inhibitor Mechanisms (6 papers) and Fibroblast Growth Factor Research (5 papers). Stephen Gately collaborates with scholars based in United States, Canada and Brazil. Stephen Gately's co-authors include Gerald A. Soff, William W. Li, Steven Brem, Robert West, Ana Maria Crous Tsanaclis, Helena J. Mauceri, Michael A. Beckett, Donald Küfe, M. Sharon Stack and Jan J. Enghild and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Stephen Gately

40 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined effects of angiostatin and ionizing radiation in antitumour therapy

1998 582 citations Helena J. Mauceri, Nader Hanna et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Gately United States	24	2.0k	1.2k	675	557	373	40	3.5k
Borhane Annabi Canada	41	2.2k 1.1×	1.2k 1.0×	1.1k 1.6×	208 0.4×	216 0.6×	151	4.8k
Francesca Bianchini Italy	38	2.4k 1.2×	1.3k 1.1×	1.3k 1.9×	253 0.5×	337 0.9×	118	4.7k
Sylvia A. Holden United States	31	2.8k 1.4×	1.6k 1.4×	1.4k 2.1×	507 0.9×	232 0.6×	85	4.4k
Claudio Festuccia Italy	45	2.8k 1.4×	1.1k 0.9×	1.6k 2.4×	230 0.4×	194 0.5×	164	5.3k
Chryso Kanthou United Kingdom	29	1.7k 0.9×	698 0.6×	614 0.9×	169 0.3×	715 1.9×	61	3.4k
Mauro Bologna Italy	36	1.7k 0.8×	722 0.6×	1.1k 1.6×	160 0.3×	184 0.5×	116	3.5k
Olivier Dormond Switzerland	33	1.7k 0.9×	584 0.5×	1.1k 1.7×	287 0.5×	119 0.3×	72	3.3k
Lido Calorini Italy	37	2.1k 1.0×	1.2k 1.0×	1.3k 1.9×	169 0.3×	339 0.9×	106	3.9k
József Tóvári Hungary	29	1.7k 0.8×	613 0.5×	1.1k 1.6×	285 0.5×	157 0.4×	143	3.1k
Diane R. Bielenberg United States	40	3.1k 1.6×	1.1k 0.9×	1.9k 2.8×	252 0.5×	100 0.3×	95	5.5k

Countries citing papers authored by Stephen Gately

Since Specialization

Citations

This map shows the geographic impact of Stephen Gately's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Gately with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Gately more than expected).

Fields of papers citing papers by Stephen Gately

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Gately. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Gately. The network helps show where Stephen Gately may publish in the future.

Co-authorship network of co-authors of Stephen Gately

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Gately. A scholar is included among the top collaborators of Stephen Gately based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Gately. Stephen Gately is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gately, Stephen. (2019). Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients. Cancer treatment and research. 178. 253–264. 28 indexed citations

Wang, Tong, Megan L. Goodall, Paul Gonzales, et al.. (2015). Synthesis of Improved Lysomotropic Autophagy Inhibitors. Journal of Medicinal Chemistry. 58(7). 3025–3035. 33 indexed citations

Goodall, Megan L., Tong Wang, Katie R. Martin, et al.. (2014). Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy. 10(6). 1120–1136. 89 indexed citations

Meechoovet, Bessie, et al.. (2011). β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites. PLoS ONE. 6(5). e19264–e19264. 134 indexed citations

Hahn, Tobias, Laurence H. Hurley, Daniel D. VonHoff, et al.. (2011). The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer. BMC Cancer. 11(1). 471–471. 18 indexed citations

Bikzhanova, G.A., et al.. (2006). Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity. 3(3-4). 209–217. 24 indexed citations

Gately, Stephen & William W. Li. (2004). Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Seminars in Oncology. 31(2 Suppl 7). 2–11. 336 indexed citations

Gately, Stephen & Robert S. Kerbel. (2003). Therapeutic Potential of Selective Cyclooxygenase-2 Inhibitors in the Management of Tumor Angiogenesis. PubMed. 37. 179–192. 100 indexed citations

Gately, Stephen, et al.. (2002). Antiangiogenic scheduling of lower dose cancer chemotherapy.. PubMed. 7(5). 427–36. 96 indexed citations

10.

Gately, Stephen. (2000). The Contributions of Cyclooxygenase-2 to Tumor Angiogenesis. Cancer and Metastasis Reviews. 19(1-2). 19–27. 316 indexed citations

11.

Stack, M. Sharon, Stephen Gately, Lisa M. Bafetti, Jan J. Enghild, & Gerald A. Soff. (1999). Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochemical Journal. 340(1). 77–77. 40 indexed citations

12.

Mauceri, Helena J., Nader Hanna, Michael A. Beckett, et al.. (1998). Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature. 394(6690). 287–291. 582 indexed citations breakdown →

13.

Soff, Gerald A., et al.. (1997). Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP.. Journal of Clinical Investigation. 100(10). 2580–2587. 100 indexed citations

14.

Gately, Stephen, et al.. (1995). Cells Transfected with the Basic Fibroblast Growth Factor Gene Fused to a Signal Sequence Are Invasive In Vitro and In Situ in the Brain. Neurosurgery. 36(4). 780–788. 17 indexed citations

15.

Gately, Stephen, Gerald A. Soff, & Steven Brem. (1995). The Potential Role of Basic Fibroblast Growth Factor in the Transformation of Cultured Primary Human Fetal Astrocytes and the Proliferation of Human Glioma (U-87) Cells. Neurosurgery. 37(4). 723???732–723???732. 2 indexed citations

16.

Soff, Gerald A., et al.. (1995). Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.. Journal of Clinical Investigation. 96(6). 2593–2600. 137 indexed citations

17.

Gately, Stephen, et al.. (1994). A diaminoantraquinone inhibitor of angiogenesis.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 1027–1033. 14 indexed citations

18.

Takano, Shingo, Stephen Gately, Herbert H. Engelhard, Ana Maria Crous Tsanaclis, & Steven Brem. (1994). Suramin inhibits glioma cell proliferationin vitro and in the brain. Journal of Neuro-Oncology. 21(3). 189–201. 36 indexed citations

19.

Tsanaclis, Ana Maria Crous, Steven Brem, Stephen Gately, Hyman M. Schipper, & Eugenia Wang. (1991). Statin immunolocalization in human brain tumors. Detection of noncycling cells using a novel marker of cell quiescence. Cancer. 68(4). 786–792. 18 indexed citations

20.

Brem, Steven, et al.. (1990). Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor.. PubMed. 137(5). 1121–42. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact